HOUSTON, April 17, 2013 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq:SMED) ("Sharps" or the "Company"), a leading full-service provider of solutions for the cost-effective management of medical waste, used healthcare materials and unused dispensed medications, announced that it will release its third quarter fiscal year 2013 results (ended March 31, 2013) before the opening of financial markets on Wednesday, May 1, 2013. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy, followed by a question-and-answer session. The Sharps conference call can be accessed by calling (201) 689-8560. The webcast can be monitored at www.sharpsinc.com . Webcast listeners will have the opportunity to submit questions to the speakers. Select questions will be summarized and addressed during the question-and-answer portion of the call. A telephonic replay will be available from 2:00 p.m. ET the day of the teleconference until Wednesday, May 8, 2013. To listen to the archived call, dial (858) 384-5517, and enter conference ID number 412288. A transcript will also be posted to Sharps' website, once available. About Sharps Compliance Corp. Headquartered in Houston, Texas, Sharps Compliance is a leading full-service provider of solutions for the cost-effective management of medical waste, used healthcare materials and unused dispensed medications. Its strategy is to capture a large part of the estimated $3.8 billion untapped market for its solutions by targeting the major agencies that are interrelated with this medical waste stream, including pharmaceutical manufacturers, home healthcare providers, retail pharmacies and clinics, the U.S. government and the professional market which is comprised of physicians, dentists and veterinary practices. As a fully integrated medical waste management company providing customer solutions and services, the Company's solid business model, which provides strong margins and significant operating leverage, combined with its early penetration into emerging markets, uniquely positions it for strong future growth.